Close Menu

Sciex

MDS Pharma Services' expansion in Taiwan is in line with the unit's decision to focus on early-stage discovery and development services.

In Brief This Week is a Friday column containing news items that our readers may have missed during the week.

Proteomics

The AB Sciex TOF/TOF 5800, which the companies said enables researchers to identify 30 percent more proteins and speed up the biomarker discovery process 10-fold, follows platform launches in the fall meant to put them back at the top of the mass-spec food chain.

Industry Briefs: Mar 19, 2009

Premium

MDS, Aushon BioSystems, Thermo Fisher Scientific, Oxford Genome Technology, Sense Proteomic, Institute for Bioanalytics, Axela, Arrayit

News Scan: Mar 13, 2009

Premium

CompuCyte, Children's Hospital Boston, US Senate, National Institutes of Health, Albert Einstein College of Medicine, Empire State Stem Cell Board, MDS, Caliper Life Sciences, CHDI, GlobalStem, ADMEcell, Advancell

The firm's Analytical Technologies segment posted a 27 percent revenue drcline, with mass spec sales down 7 percent year over year.

The firms will combine Innovative Biosensors' antibody technology with ProGenTech's Enture Lite platform to create a rapid diagnostic system.

The change removes "drag from the revenue" but could also fuel speculation that Life Tech is considering divesting the unit. Officials reiterated the firm’s intent to "run the business for success."

News Scan: Feb 6, 2009

Premium

MDS, Cenix BioScience, Boehringer Ingelheim, Life Technologies, Molecular Devices

Pages

At a meeting this week, researchers and others discussed the regulatory oversight needed for germline genome editing.

The US Food and Drug Administration has asked questions about Myriad Genetics' GeneSight test, according to Bloomberg.

Researchers report that neutrophil extracellular traps appear to binds gallstones together, according to New Scientist.

In Science this week: approach to infer genotype-by-environment interaction from genetic variants associated with phenotypic variability, and more.